Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 2a,Condition 2b,Condition 2c,Condition 3
2561,"Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000.",glomerular filtration trait,,RS:0000592,MW,male,0 days,8,,CMO:0000490,glomerular filtration rate,,,,0.6,ml/min,0.07,0.198,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,5/6 nephrectomy,28,days,nephrectomy (for 28 days) then control condition,100992,nephrectomy (for 28 days),,control condition,,,
2561,"Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000.",glomerular filtration trait,,RS:0000592,MW,male,0 days,8,,CMO:0000490,glomerular filtration rate,,,,0.54,ml/min,0.05,0.1414,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,5/6 nephrectomy,28,days,nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days),100993,nephrectomy (for 28 days),,enalapril (50 mg/l) (for 21 days),,,
2561,"Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000.",glomerular filtration trait,,RS:0000592,MW,male,0 days,8,,CMO:0000490,glomerular filtration rate,,,,0.61,ml/min,0.08,0.2263,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,5/6 nephrectomy,28,days,nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days),100994,nephrectomy (for 28 days),,reserpine (5 mg/l) (for 21 days),hydralazine (80 mg/l) (for 21 days),controlled hydralazine content drinking water (25 mg/l) (for 21 days),
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,6,,CMO:0000490,glomerular filtration rate,,,,0.05,ml/min,0.01,0.0245,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days),100883,right nephrectomy (for 112 days),,,,,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,10,,CMO:0000490,glomerular filtration rate,,,,0.32,ml/min,0.01,0.0316,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days),100884,right nephrectomy (for 112 days),,reserpine (5 mg/l) (for 56 days),hydralazine (80 mg/l) (for 56 days),controlled hydralazine content drinking water (25 mg/l) (for 56 days),
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,10,,CMO:0000490,glomerular filtration rate,,,,0.67,ml/min,0.1,0.3162,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days),100885,right nephrectomy (for 112 days),,captopril (30 mg/kg/d) (for 56 days),,,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,9,,CMO:0000490,glomerular filtration rate,,,,0.38,ml/min,0.1,0.3,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then enalapril (20 mg/kg/d) (for 56 days),100886,right nephrectomy (for 112 days),,enalapril (20 mg/kg/d) (for 56 days),,,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,10,,CMO:0000490,glomerular filtration rate,,,,0.36,ml/min,0.05,0.1581,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then lisinopril (10 mg/kg/d) (for 56 days),100887,right nephrectomy (for 112 days),,lisinopril (10 mg/kg/d) (for 56 days),,,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,7,,CMO:0000490,glomerular filtration rate,,,,0.36,ml/min,0.06,0.1587,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then angiotensin II receptor antagonist (20 mg/l) (for 56 days),100888,right nephrectomy (for 112 days),,angiotensin II receptor antagonist (20 mg/l) (for 56 days),,,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,5,,CMO:0000490,glomerular filtration rate,,,,0.42,ml/min,0.06,0.1342,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then angiotensin II receptor antagonist (80 mg/l) (for 56 days),100889,right nephrectomy (for 112 days),,angiotensin II receptor antagonist (80 mg/l) (for 56 days),,,
2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",glomerular filtration trait,,RS:0000592,MW,male,0 days,6,,CMO:0000490,glomerular filtration rate,,,,0.57,ml/min,0.07,0.1715,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,70,days,unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) ,101204,unilateral nephrectomy (for 70 days),,puromycin aminonucleoside (100 mg/kg) ,,,puromycin aminonucleoside (40 mg/kg)
2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",glomerular filtration trait,,RS:0000592,MW,male,0 days,7,,CMO:0000490,glomerular filtration rate,,,,1.46,ml/min,0.08,0.2117,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,70,days,unilateral nephrectomy (for 70 days) then vehicle control condition,101205,unilateral nephrectomy (for 70 days),,vehicle control condition,,,
2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",glomerular filtration trait,,RS:0000592,MW,male,0 days,5,,CMO:0000490,glomerular filtration rate,,,,0.94,ml/min,0.11,0.246,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,70,days,unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) ,101206,unilateral nephrectomy (for 70 days),captopril (500 mg/l) (for 70 days),puromycin aminonucleoside (100 mg/kg) ,,,puromycin aminonucleoside (40 mg/kg)
2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",glomerular filtration trait,,RS:0000592,MW,male,0 days,7,,CMO:0000490,glomerular filtration rate,,,,0.41,ml/min,0.1,0.2646,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,doxorubicin,29,days,doxorubicin (2 mg/kg) ,101207,doxorubicin (2 mg/kg) ,,,,,
2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",glomerular filtration trait,,RS:0000592,MW,male,0 days,18,,CMO:0000490,glomerular filtration rate,,,,0.99,ml/min,0.08,0.3394,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,control,29,days,control condition,101208,control condition,,,,,